Park Medi World Limited has announced key appointments within its corporate governance framework following its Board of Directors meeting held on May 15, 2026. The Board has officially approved the appointment of new auditors to enhance the company’s compliance and financial oversight for the coming fiscal years. These appointments include Sachin Gupta & Co. as Cost Auditor and NKSC & Co. as Internal Auditor for the financial year 2026-27, alongside SBR & Co. LLP as Secretarial Auditor for a five-year term spanning from 2025-26 to 2029-30, subject to shareholder approval at the ensuing Annual General Meeting.

The Board, upon the recommendation of the Audit Committee, formalized these appointments to ensure robust internal controls and regulatory adherence. Sachin Gupta & Co. is a leading cost accountancy firm registered with the ICAI, specializing in cost audit, consultancy, and company law compliances. NKSC & Co. brings over 20 years of expertise with a large team of domain experts, including Chartered Accountants and financial analysts. SBR & Co. LLP, headquartered in Mumbai with a national presence, will oversee secretarial and legal services, ensuring compliance with the Companies Act, 2013, and SEBI regulations.

Park Medi World Limited, operating under the brand ‘Park Hospital’, is the second-largest private hospital chain in North India, focusing on a cluster-based ‘buy and fix’ business model. The company operates a network of NABH-accredited multi-super specialty hospitals, offering over 30 specialties including oncology, neurology, and cardiology. Throughout 2025, the company aggressively expanded its footprint, including the acquisition of KP Institute of Medical Sciences for ₹245 crore and Krishna Super-speciality Hospital, aiming to increase its capacity to 4,900 beds by 2028. The company successfully completed its Initial Public Offering (IPO) in December 2025, which was subscribed 8.10 times, to support debt repayment and capital expenditure for new hospital developments in regions like Ambala, Panchkula, and Rohtak.

In the most recent fiscal year 2026, the company demonstrated strong financial performance, reporting revenue of ₹17.1 billion, representing a 23% increase over fiscal year 2025. Net income for the full year 2026 rose to ₹2.58 billion, a 26% growth compared to the previous year, with a consistent profit margin of 15%. The company’s growth is supported by institutional interest, with notable investors such as Kotak Mahindra Asset Management and Carnelian Asset Management holding significant stakes in the firm.